References
- Her M, Kim D, Oh M, . Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus. Lupus 2009;18:501–507.
- Hutloff A, Dittrich AM, Beier KC, . ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999;397:263–266.
- Ling V, Wu PW, Finnerty HF, . Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J Immunol 2000;164:1653–1657.
- Freedman AS, Freeman GJ, Rhynhart K, . Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol 1991;137:429–437.
- Linsley PS, Clark EA, Ledbetter JA. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 1990;87:5031–5035.
- Yokochi T, Holly RD, Clark EA. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. J Immunol 1982;128:823–827.
- Bretscher P, Cohn M. A theory of self-nonself discrimination. Science 1970;169:1042–1049.
- Subudhi SK, Zhou P, Yerian LM, . Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J Clin Invest 2004;113:694–700.
- Swallow MM, Wallin JJ, Sha WC. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity 1999; 11:423–432.
- Chen XL, Cao XD, Kang AJ, . In situ expression and significance of B7 costimulatory molecules within tissues of human gastric carcinoma. World J Gastroenterol 2003;9:1370–1373.
- Schreiner B, Wischhusen J, Mitsdoerffer M, . Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivo. Glia 2003;44:296–301.
- Wang S, Zhu G, Chapoval AI, . Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 2000;96:2808–2813.
- Yoshinaga SK, Whoriskey JS, Khare SD, . T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999;402:827–832.
- Liang L, Sha WC. The right place at the right time: novel B7 family members regulate effector T cell responses. Curr Opin Immunol 2002;14:384–390.
- Flies DB, Chen L. Modulation of immune response by B7 family molecules in tumor microenvironments. Immunol Invest 2006;35: 395–418.
- Flies DB, Chen L. The new B7s: playing a pivotal role in tumor immunity. J Immunother 2007;30:251–260.
- Liu X, Bai XF, Wen J, . B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8 (+) T lymphocytes in vivo. J Exp Med 2001;194:1339–1348.
- Wallin JJ, Liang L, Bakardjiev A, . Enhancement of CD8+ T cell responses by ICOS/B7h costimulation. J Immunol 2001;167: 132–139.
- Tamura H, Dan K, Tamada K, . Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia. Clin Cancer Res 2005;11:5708–5717.
- Yamashita T, Tamura H, Satoh C, . Functional B7.2 and B7-H2 molecules on myeloma cells are associated with a growth advantage. Clin Cancer Res 2009;15:770–777.
- Vieira PL, Wassink L, Smith LM, . ICOS-mediated signaling regulates cytokine production by human T cells and provides a unique signal to selectively control the clonal expansion of Th2 helper cells. Eur J Immunol 2004;34:1282–1290.
- Coyle AJ, Lehar S, Lloyd C, . The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 2000;13:95–105.
- Wang F, Zhu W, Liu T, . The expression analysis of ICOS-L on activated T cells and immature dendritic cells as well as malignant B cells and Grave's-disease-derived thyroid tissues by two novel mAbs against human ICOS-L. Tissue Antigens 2007;69:62–72.
- Ara G, Baher A, Storm N, . Potent activity of soluble B7RP-1-Fc in therapy of murine tumors in syngeneic hosts. Int J Cancer 2003;103:501–507.
- Hubbard VM, Eng JM, Ramirez-Montagut T, . Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation. Blood 2005;106:3285–3292.
- Marcusson-Ståhl M, Cederbrant K. A flow-cytometric NK-cytotoxicity assay adapted for use in rat repeated dose toxicity studies. Toxicology 2003;193:269–279.
- Goldberg JE, Sherwood SW, Clayberger C. A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two-color flow cytometry. J Immunol Methods 1999;224:1–9.
- Godoy-Ramirez K, Mäkitalo B, Thorstensson R, . A novel assay for assessment of HIV-specific cytotoxicity by multiparameter flow cytometry. Cytometry A 2005;68:71–80.
- Gonzalo JA, Tian J, Delaney T, . ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Nat Immunol 2001;2:597–604.
- Tesciuba AG, Subudhi S, Rother RP, . Inducible costimulator regulates Th2-mediated inflammation, but not Th2 differentiation, in a model of allergic airway disease. J Immunol 2001;167:1996–2003.
- Frauwirth KA, Thompson CB. Activation and inhibition of lymphocytes by costimulation. J Clin Invest 2002;109:295–299.
- Grimbacher B, Warnatz K, Peter HH. The immunological synapse for B-cell memory: the role of the ICOS and its ligand for the longevity of humoral immunity. Curr Opin Allergy Clin Immunol 2003;3:409–419.